エスカレートされた静脈注射から皮下注射のインフリキシマブへの切り替えを最適化:集団の薬理動力学-薬理動力学研究
Zhigang Wang1, Marc Ferrante2,3, Séverine Vermeire2,3
1Department of Pharmaceutical and Pharmacological Sciences, KU Leuven, Leuven, Belgium.
Journal of Crohn's & colitis
|August 28, 2025
まとめ
静脈注射から皮下注射のインフリキシマブに切り替えられた患者は,治療効果を維持することができる. この研究は,クローン病と潰瘍性大腸炎の患者にとって,皮下注射のインフリキシマブへの移行が安全で有効であることを示しています.
科学分野:
- 胃腸内科
- 薬理学について
- 臨床療法
背景:
- 静脈内 (IV) のエスカレート投与からCT- P13 (週2回120mg) の標準の皮下投与 (SC) への移行の有効性については,不確実性があります.
- この研究は,クローン病 (CD) と潰瘍性大腸炎 (UC) の患者における,IVからSCへのインフリキシマブスイッチの投与時の投与量-曝露-反応の関係に関するものです.
研究 の 目的:
- インフリキシマブをIV投与からSC投与に移行する際の投与量-暴露-反応の関係を調べる.
- CDとUC患者の治療応答マーカーの切り替えの影響を評価する.
主な方法:
- 健康なボランティアとCDとUCの患者を対象とした第I相試験のデータを用いて,集団の薬学動力学モデルとシミュレーションを行いました.
- 内カルプロテクチン (FC),CDにおける内視寛解 (ER),UCにおける内視改善 (EI) は,IVからSCインフリキシマブへの移行中に測定された.
- シミュレーションには,1000人の仮想患者が参加し,FCレベルとER/EIの確率を評価した.
主要な成果:
- FC濃度の低下は,インフリキシマブ全体の曝露の増加と相関する.
- 14週間の低FCは,UCにおけるEIの確率を予測したが,CDではERを予測しなかった.
- シミュレーションにより,第6週にSCインフリキシマブに切り替えると,FCが改善され,EIの確率は増加しました.
- エスカレートされたIV維持療法 (10 mg/ kg Q6W/ Q8Wまで) を受けている仮想患者は,FC増加なしに120 mg Q2W SCインフリキシマブに切り替えることができる.
- インフリキシマブをIVからSCに切り替えるための臨床ソフトウェアツールが開発されました.
結論:
- Q6WとQ8WのIV療法の患者は,FCの上昇を経験することなく,標準のSCのインフリキシマブに移行することができます.
- この研究は,インフリキシマブ製剤の変更に関する臨床的決定を導き,治療効果の維持を保証するモデルを提供します.
関連する概念動画
01:09One-Compartment Model: IV Infusion
280
Intravenous (IV) infusion is often utilized when continuous and controlled drug delivery is necessary, such as during surgery or in the treatment of chronic diseases. This method offers numerous advantages, including immediate drug action, precise control over dosage, and bypassing the first-pass metabolism.
The one-compartment model for IV infusion uses mathematical equations to describe the rate of change in drug quantity in the body. At steady-state or infusion equilibrium, the drug input...
The one-compartment model for IV infusion uses mathematical equations to describe the rate of change in drug quantity in the body. At steady-state or infusion equilibrium, the drug input...
280
01:18Two-Compartment Open Model: IV Bolus Administration
696
The two-compartment model for intravenous (IV) bolus administration illustrates drug distribution in the body, subdividing it into central and peripheral compartments. This model operates on the concept of two-compartment kinetics. The drug's plasma concentration shows a bi-exponential decline following IV bolus administration, signaling the presence of two disposition processes: distribution and elimination.
The disparity between drug input and the sum of drug transfer rates between...
The disparity between drug input and the sum of drug transfer rates between...
696
00:59Nonlinear Pharmacokinetics: Drug Elimination for IV Bolus Injection
148
In pharmacokinetics, the elimination rate of a drug following a capacity-limited model is primarily controlled by two parameters: Vmax and KM. These parameters are crucial in how the drug behaves inside the body after administration.
Following the administration of a single intravenous (IV) bolus injection, we can determine the concentration of the drug in the plasma at any given time. This calculation is achieved using a specific equation that integrates the values of Vmax and KM.
We can also...
Following the administration of a single intravenous (IV) bolus injection, we can determine the concentration of the drug in the plasma at any given time. This calculation is achieved using a specific equation that integrates the values of Vmax and KM.
We can also...
148
01:15Two-Compartment Open Model: IV Infusion
331
A two-compartment model is a vital tool in pharmacokinetics, providing an essential understanding of drug behavior, especially for those administered via zero-order intravenous infusion. This model outlines two compartments: the central compartment, where elimination occurs, and the peripheral compartment.
The model illustrates the decrease in plasma drug concentration from the central compartment with a specific equation. It shows that under steady-state conditions, the drug's input rate...
The model illustrates the decrease in plasma drug concentration from the central compartment with a specific equation. It shows that under steady-state conditions, the drug's input rate...
331
01:25Routes of Drug Administration: Parenteral
2.1K
The administration of drugs via parenteral routes allows for direct drug introduction into the systemic circulation, resulting in high bioavailability because the medication bypasses the harsh conditions of the gastrointestinal tract and hepatic metabolism.
The intravenous route (IV) of drug administration can be further categorized into two types. The bolus injection administers the entire dose rapidly, while an intravenous infusion slowly delivers smaller doses steadily.
The IV route is often...
The intravenous route (IV) of drug administration can be further categorized into two types. The bolus injection administers the entire dose rapidly, while an intravenous infusion slowly delivers smaller doses steadily.
The IV route is often...
2.1K
01:19One-Compartment Open Model for IV Bolus Administration: General Considerations
315
The one-compartment model is a pharmacokinetic tool that models the body as a single, uniform compartment, facilitating the understanding of drug distribution and elimination. This model is particularly beneficial for intravenous (IV) bolus administration, where the drug rapidly circulates throughout the body.
The drug's presence in the body is defined by an equation representing the difference between the rates of drug entry and exit. Key parameters—elimination rate constant,...
The drug's presence in the body is defined by an equation representing the difference between the rates of drug entry and exit. Key parameters—elimination rate constant,...
315